- Lobbying
- Lobbying by Centrient Pharmaceuticals LLC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Daniel Graver | Leg asst, Rep Giffords, 2007-08; leg aide, Rep Grijalva, 2005 Leg asst, Rep Giffords, 2007-08; leg aide, Rep Grijalva, 2005 |
Geoff Verhoff | Press aide, ofc of Sen Roth, Nov 00-Jan 01; press aide, S Fin Comm, Aug 99-Nov 00 |
Matt Hittle | Staff Asst, H Comm W&M May, 11-Jan. 12; Sr Staff Asst, H Comm W&M, Jan 12-May 12; Leg Asst, H Comm on W&M Ovrst Subcom, May 12-Feb 15; Sr Leg Asst, Rep Noem, Feb. 15-March 17; LD, Rep. Noem, March 17-Dec 18; Sr Advisr to Administr, CMS, Dec 18-Dec 20 |
Anna Abram | Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 |
Louis Agnello | Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08 Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08. |
Steve Kho | Associate General Counsel, Acting Chief Counsel for China Enforcement, USTR, 1998-2007; Legal Advisor, U.S. Mission to the WTO, 2002-2005 |
Ed Pagano | Advsr, Sen Harkin, 2014; Dep Asst to the President for Leg Affairs and Sen Liaison, Exec Ofc of the President, 2012-14; CoS, Sen Leahy, 2005-11; Sr Cnsl, Sen Judiciary Comm, 1997-04 |
Casey Higgins | Asst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19; Trade Cncl to House Ways & Means, Jan 15-Nov 15; LC to Rep. Paul Ryan, Oct 11-Jan 15; Law Clrk House Budget Comm, Sep 09-May 10. |
Charlie Johnson | n/a |
Heide Bajnrauh | n/a |
Sean Feely | n/a |
Matthew Hittle | n/a |
Mario Ramirez | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Pharmacy
Manufacturing
Q3 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Natl Security Council (NSC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Office of Science & Technology Policy (OSTP)
Natl Economic Council (NEC)
Natl Security Council (NSC)
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
White House Office
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Commerce - Dept of (DOC)
White House Office
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
State - Dept of (DOS)
U.S. Trade Representative (USTR)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
State - Dept of (DOS)
U.S. Trade Representative (USTR)
Type of Issue
Lobbying Issues
Agencies Lobbied
Commerce - Dept of (DOC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
State - Dept of (DOS)
U.S. Trade Representative (USTR)
Type of Issue
Lobbying Issues
Agencies Lobbied
Commerce - Dept of (DOC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Health & Human Services - Dept of (HHS)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Health & Human Services - Dept of (HHS)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
U.S. Senate
Natl Security Council (NSC)
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Natl Economic Council (NEC)
Natl Security Agency (NSA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Economic Council (NEC)
Natl Security Council (NSC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Overseas Private Investment Corp (OPIC)
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
Overseas Private Investment Corp (OPIC)
Type of Issue
Manufacturing
Pharmacy
Registration
Issue(s) they said they’d lobby about: Reshoring production of essential medicines..
Registration
Issue(s) they said they’d lobby about: Reshoring production of essential medicines..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate